Polar Capital Global Healthcare Trust plc (PCGH) Ordinary 25p Shares

Sell:407.00pBuy:409.00p4.00p (0.99%)

FTSE All Share:0.99%
Market closed |
Prices delayed by at least 15 minutes
Sell:407.00p
Buy:409.00p
Change:4.00p (0.99%)
Market closed |
Prices delayed by at least 15 minutes
Sell:407.00p
Buy:409.00p
Change:4.00p (0.99%)
Market closed |
Prices delayed by at least 15 minutes

Trust Information

About this company

Polar Capital Global Healthcare Trust Plc is an investment trust. The Company's Objective is to generate capital growth by investing in a global portfolio of healthcare stocks. The Company seeks to achieve its objective by investing in a diversified global portfolio consisting primarily of listed equities. The portfolio is diversified by geography, industry subsector and investment size. Stock selection is central to the process, looking to identify companies where there is a disconnect between valuations and the near and medium-term growth drivers. The Company is focused primarily on healthcare companies with resilient and medium-term growth profiles. It also has the opportunity to invest in earlier-stage companies. It invests in various sectors, including pharmaceuticals, managed healthcare, healthcare equipment, healthcare services, healthcare supplies, life sciences tools & services. The Company’s investment manager and alternative investment fund manager is Polar Capital LLP.

Objective

The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.

Costs

  • Ongoing charge0.89%
  • Annual management charge -
  • Performance feeYes

Fee structure

Management fee is 0.75% p.a. of the lower of the Market Capitalisation and NAV. Performance fee is equal to 10% of the excess total return over benchmark Index plus 1.5% p.a. compounded annually. Agreement terminable not less than 12 months written notice.

Value Assessment

  • Value Assessment review date30 May 2025
  • Value Assessment next review date-
  • Is Assessment of Value required under COLL?No
  • Outcome of COLL Assessment of Valuen/a
  • Outcome of PRIN Value Assessment or reviewProduct expected to provide fair value for reasonably foreseeable period
  • Other review related to value and or charges -
  • Further information-
Click to see more

Key facts

  • Currency
    GBX
  • Benchmark
    MSCI ACWI/Health Care NR GBP enhanced
  • Shares in issue
    124.15m
  • Gross gearing
    0.00%
  • EPIC
    PCGH
  • ISIN
    GB00B6832P16
  • Domicile
    United Kingdom
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.